Thursday, November 16, 2023, 4:00pm – 5:30 PM Eastern Time
During this webinar, Dr. Andrew Nierenberg of Massachusetts General Hospital will give an overview of the most up-to-date research and current data available on the long-term course of Bipolar Depression and its treatment. Dr. Nierenberg will share information about the latest treatment options, inspiring hope in audience members that recovery is possible.
Dr. Andrew Nierenberg graduated from the Albert Einstein College of Medicine of Yeshiva University, Bronx, NY. After completing his residency in psychiatry at New York University/Bellevue Hospital, he studied clinical epidemiology at Yale University as a Robert Wood Johnson Clinical Scholar. Dr. Nierenberg then joined the faculty at Harvard Medical School, first at McLean Hospital in Belmont, Massachusetts, and then at Massachusetts General Hospital. He is also an Honorary Professor in the School of Medicine, Faculty of Health at Deakin University, Geelong, Australia (where he served as a Thinker in Residence), and an Honorary Skou Professor at Aarhus University in Denmark.
Dr. Nierenberg has published over 580 papers and has been listed in The Best Doctors in America or Top Doctors or Best Doctors in Boston for the treatment of mood and anxiety disorders every year since 1994. In 2000, he was awarded the Gerald L. Klerman Young Investigator Award, and in 2014 the Gerald L. Klerman Senior Investigator Award by the Depression Bipolar Support Alliance. In 2013, Dr. Nierenberg was awarded the prestigious Brain and Behavior Research Foundation Colvin Prize for outstanding achievement in mood disorders research.
Dr. Nierenberg’s primary interests are improving the use of existing treatments and finding innovative treatments for bipolar disorder. He lectures extensively nationally and internationally, teaches, supervises, maintains an active clinical practice, consults with industry, and conducts clinical trials funded by federal, foundation, industry, and philanthropic sources. He serves as a peer reviewer for over 35 psychiatric journals and he is a member of the editorial boards of over 15 journals.